Effects of elevated bile acid levels on fetal myocardium in intrahepatic cholestasis of pregnancy, a retrospective study from a neonatal perspective [0.03%]
从新生儿角度回顾性研究妊娠期肝内胆汁淤积症高胆汁酸水平对胎儿心肌的影响
Junnai Wang,Weiwei Lun,Wei Shi
Junnai Wang
Aim: Intrahepatic cholestasis of pregnancy (ICP) is a liver disease which may lead to a sudden fetal death.Previous studies have suggested that the fetal accident may be related to their cardiac dysfunction.However,the re...
Quantitative changes of lipoprotein(a) in chronic hepatitis C patients achieving a sustained virological response by direct-acting antivirals [0.03%]
直接抗病毒药物治疗后慢性丙型肝炎患者获得持续病毒学应答者的Lp（a）定量变化
Taiki Okumura,Satoru Joshita,Ayumi Sugiura et al.
Taiki Okumura et al.
Plasma exchange for patients with acute or acute on chronic liver failure; meta-analysis of randomized controlled trials [0.03%]
急性或慢性肝衰竭患者血浆置换疗法的meta分析研究
Mohamed M G Mohamed,Ali Osman,Hani El-Halawany
Mohamed M G Mohamed
Identification of differentially expressed miRNAs and key genes involved in the progression of alcoholic fatty liver disease using rat models [0.03%]
基于大鼠模型的酒精性脂肪肝病差异表达miRNA和关键基因识别研究
Xuemei Zhang,Wenqi Song,Mingxuan Zhang et al.
Xuemei Zhang et al.
Background: Alcoholic fatty liver disease (AFLD) is a liver disease caused by prolonged heavy drinking and has a poor prognosis in the clinic. This study aimed to explore the differential miRNAs expression profiles in the...
Correlation between efficacy endpoints in patients with advanced biliary tract cancer treated by systemic second-line therapies: Analysis of aggregated data from a systematic literature review [0.03%]
系统回顾文献汇总数据的二期全身治疗晚期胆道癌患者的疗效终点相关性分析
Cindy Neuzillet,David Malka,Astrid Lièvre et al.
Cindy Neuzillet et al.
Background: Overall response rate (ORR) and progression-free survival (PFS) are commonly used as endpoints for phase II trials. However, the ultimate goal is to bring survival benefit for the patients. We aimed to assess ...
The progression of chronicity and autoimmune hepatitis in recurrent drug-induced liver injury [0.03%]
反复药物性肝损伤慢性化及自身免疫性肝炎样改变的演变规律分析
Tingting He,Lutong Ren,Man Gong et al.
Tingting He et al.
Background and aims: Recurrent drug-induced liver injury (DILI) is not well documented. We retrospectively analysed the characteristics of patients who had a history of two separate DILI episodes due to different drugs. ...
Association of serum C-peptide with all-cause and cardiovascular disease mortality in ultrasound-defined nonalcoholic fatty liver disease [0.03%]
基于超声检查定义的非酒精性脂肪肝病患者中西利肽与全因及心血管疾病死亡率的相关性研究
Enfa Zhao,Shimin Chen
Enfa Zhao
Objective: To determine the prognostic value of C-peptide in long-term nonalcoholic fatty liver disease (NAFLD) mortality. Methods: A t...
No differences in the risk of hepatocellular carcinoma from using direct-acting antiviral agents or interferon in patients with chronic hepatitis C: A meta-analysis [0.03%]
直接抗病毒药物与干扰素治疗慢性丙型肝炎患者发生肝细胞癌风险的meta分析：二者无显著差异
Xueying Yang,Nan Wang,Si Li et al.
Xueying Yang et al.
Dixa Sharma,Palash Mandal
Dixa Sharma
Worldwide non-alcoholic fatty liver disease (NAFLD) is recognized as the most common type of liver disease and its burden increasing at an alarming rate. NAFLD entails steatosis, fibrosis, cirrhosis, and, finally, hepatocellular carcinoma (...
Acute fulminant hepatitis related to the use of dasatinib: First case report [0.03%]
达沙替尼使用相关的急性爆发性肝炎：首例报道
Morgane Clément,Jean-Paul Cervoni,Florian Renosi et al.
Morgane Clément et al.